AU2003291264A1 - Sulfonamides - Google Patents
SulfonamidesInfo
- Publication number
- AU2003291264A1 AU2003291264A1 AU2003291264A AU2003291264A AU2003291264A1 AU 2003291264 A1 AU2003291264 A1 AU 2003291264A1 AU 2003291264 A AU2003291264 A AU 2003291264A AU 2003291264 A AU2003291264 A AU 2003291264A AU 2003291264 A1 AU2003291264 A1 AU 2003291264A1
- Authority
- AU
- Australia
- Prior art keywords
- sulfonamides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42416202P | 2002-11-06 | 2002-11-06 | |
US60/424,162 | 2002-11-06 | ||
PCT/US2003/035369 WO2004043948A1 (en) | 2002-11-06 | 2003-11-06 | Sulfonamides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003291264A1 true AU2003291264A1 (en) | 2004-06-03 |
Family
ID=32312762
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003287529A Abandoned AU2003287529A1 (en) | 2002-11-06 | 2003-11-06 | Sulfonamides |
AU2003291264A Abandoned AU2003291264A1 (en) | 2002-11-06 | 2003-11-06 | Sulfonamides |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003287529A Abandoned AU2003287529A1 (en) | 2002-11-06 | 2003-11-06 | Sulfonamides |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR041885A1 (en) |
AU (2) | AU2003287529A1 (en) |
TW (1) | TW200418831A (en) |
WO (2) | WO2004043463A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0414777A (en) | 2003-09-26 | 2006-11-21 | Actelion Pharmaceuticals Ltd | compounds, pharmaceutical compositions, use of one or more compounds, and method of treating a patient suffering from a disorder |
KR101271372B1 (en) | 2004-10-12 | 2013-06-07 | 액테리온 파마슈티칼 리미티드 | 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salts |
CL2007002097A1 (en) | 2006-07-20 | 2008-01-18 | Smithkline Beecham Corp | Compounds derived from pyrrolidine or morpholine antagonists of urotensin ii; pharmaceutical composition comprising said compounds; and its use to treat congestive heart failure, ischemic heart failure, angina, myocardial ischemia, overactive bladder, asthma and / or copd, among others. |
JP5860045B2 (en) | 2010-07-09 | 2016-02-16 | ファイザー・リミテッドPfizer Limited | Compound |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3378565A (en) * | 1966-04-25 | 1968-04-16 | Dow Chemical Co | Sulfamoylpyridyl phosphorothioates and intermediates therefor |
US5338739A (en) * | 1994-03-10 | 1994-08-16 | Hoechst-Roussel Pharmaceuticals Inc. | (Pyrrolidinyl)phenyl carbamates, compositions and use |
TW324008B (en) * | 1995-03-13 | 1998-01-01 | Ishihara Sangyo Kaisha | Pyridone sulfonylurea compound, its production process and weed killer containing such compound |
-
2003
- 2003-11-04 AR ARP030104038A patent/AR041885A1/en unknown
- 2003-11-04 TW TW092130759A patent/TW200418831A/en unknown
- 2003-11-06 WO PCT/US2003/035370 patent/WO2004043463A2/en not_active Application Discontinuation
- 2003-11-06 WO PCT/US2003/035369 patent/WO2004043948A1/en not_active Application Discontinuation
- 2003-11-06 AU AU2003287529A patent/AU2003287529A1/en not_active Abandoned
- 2003-11-06 AU AU2003291264A patent/AU2003291264A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004043463A3 (en) | 2004-06-17 |
TW200418831A (en) | 2004-10-01 |
WO2004043463A2 (en) | 2004-05-27 |
AR041885A1 (en) | 2005-06-01 |
WO2004043948A1 (en) | 2004-05-27 |
AU2003287529A1 (en) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002335152A1 (en) | Robot-phone | |
AU2002367810A1 (en) | Bis-transition-metal-chelate-probes | |
AU2003291303A1 (en) | Sulfonamides | |
AU2002256497A1 (en) | Sulfonamides | |
AU2003295408A1 (en) | Sulfonamides | |
AU2003291255A1 (en) | Sulfonamides | |
AU2003291262A1 (en) | Sulfonamides | |
AU2003291264A1 (en) | Sulfonamides | |
AU2002318053A1 (en) | Suplier | |
AU2002368348A1 (en) | Electrosomatogram | |
AU2003214472A1 (en) | Sulfonamide derivatives | |
AU2002341221A1 (en) | Honey-brandy | |
AU2002348964A1 (en) | Snowbike | |
AU2002344387A1 (en) | Multifunction-pillow | |
AU2002100482A4 (en) | Tail-gate-ezy | |
AU2002100498A4 (en) | Linline | |
AU2002100160A4 (en) | Oxidirator | |
AU2002100026A4 (en) | Disc400 | |
AU2002100468A4 (en) | Flexi-edger | |
AU2002100031A4 (en) | earliPay | |
AU2002100510A4 (en) | Bottlenecker | |
AU2002100280A4 (en) | Proshoe | |
AU2002100508A4 (en) | Photocard | |
AU2002100957A4 (en) | Sluggit | |
AU2002100747A4 (en) | Powersell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |